Social interaction impairment, hyperactivity, and decreased depression-like and anxiety-like behavior; increased neurotransmitters including serotonin, norepinephrine, and dopamine in different brain regions; decreased monoamine oxidase A. The gene discussed is MAOA; the disease is depressive symptom measurement.